One of the leaders in the field of genetics, Chinese Beijing Genome Institute, BGI, has increased its collaboration with PentaBase, Denmark
Following a successful first benchmark of PentaBase's technologies against competing technologies, BGI (together with Danish BGI partner SD Genomics) and PentaBase have now strengthened their collaboration with the aim to co-develop outstanding kits for the detection of important clinical biomarkers.
It says it believes that combining world leading bioinformatics with outstanding and robust technology offers great perspectives in developing diagnostic kits second to none.
The kits will be based on real-time PCR.
With the general trend pointing towards personalised medicine, development of robust, sensitive and specific genetic diagnostics is essential.
BGI, SD Genomics and PentaBase want to launch a range of ground breaking diagnostic assays.
It is a perfect fit between two parties with complementary knowledge and technology.
"We have magnificent perspectives in creating a win-win situation," says Ulf Christensen, CEO, PentaBase.
